5 Dec 2016 11:13
Bioquell PLC
("Bioquell" or the "Company")
Purchase of own shares
Further to the Company's announcement on 7 November 2016 stating its intention to reduce its capital by means of purchasing its shares from time to time using existing cash resources of up to £2.5 million, the Company announces that on 2 December 2016 it purchased 940,000 of its ordinary shares on the London Stock Exchange at a price of 135 pence per share. The purchased shares will all be held as treasury shares.
Aggregated information:
Date of purchase: | 2 December 2016 |
Number of ordinary shares purchased: | 940,000 |
Volume weighted average price paid per share: | 135 pence |
Transaction details:
Issuer name: | Bioquell Plc | |||
ISIN: | GB0004992003 | |||
Timezone: | GMT | |||
Currency: | GBP |
|
|
|
Total Number of Voting Rights
In accordance with DTR 5.6.1 of the FCA's Disclosure Guidance and Transparency Rules, the Company is required to notify the market of the total number of voting rights and capital in the Company as at the end of each calendar month in which an increase or decrease has occurred.
The issued share capital of the Company is comprised of 22,941,434 ordinary shares of 10p each. As 940,000 of these ordinary shares are held as treasury shares, the total number of voting rights in the Company is 22,001,434. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries:
Bioquell PLC Ian Johnson - Chairman Michael Roller - Finance Director
| 01264 835 900 |
N+1 Singer Nic Hellyer - Managing Director | 020 7496 3000 |
Bioquell (BQE)